Skip to content

Study · Measured the body's own peptide · 1983

1 result

Immunological characterization of homosexual males.

Reuben JM, Hersh EM, Mansell PW, Newell G, Rios A, Rossen R, Goldstein AL, McClure JE

Cancer research1 Feb 1983Cited by 62 (Europe PMC)

PMID6600216 (opens in a new tab)PepBankPUB-06600216

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    Young homosexual men with the prodrome of the immune-deficiency syndrome had higher serum thymosin alpha‑1 than 21 normal heterosexual individuals.

    In plain wordsYoung men with the prodrome had higher levels of the body's own thymosin alpha‑1 than healthy heterosexual people did.

    Outcome
    IncreaseSerum thymosin alpha 1 level
    Study

    n = 33

    Comparator
    21 normal heterosexual individuals
    Outcome group
    Immune response · Immune and inflammation

    Measurements

    serum thymosin alpha 1
    1473 pg/ml
    homosexual men
    serum thymosin alpha 1
    524 pg/ml
    normal heterosexual individuals

    Source sentences

    Summary
    an elevated serum thymosin alpha 1 level (1473 versus 524 pg/ml, p less than or equal to 0.001
    1 context sentence
    Summary · context
    To help clarify the nature and pathogenesis of the syndrome of severely opportunistic infection associated with immune deficiency in young homosexual males, we investigated the immunological characteristics of a group of 33 young homosexual men.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.